Autifony swings $770.5m deal with Jazz for CNS drugs

cafead

Administrator
Staff member
  • cafead   Nov 14, 2023 at 09:22: AM
via UK biotech Autifony has signed an exclusive licensing deal with Jazz Pharmaceuticals, giving the Ireland-headquartered drugmaker global rights to a pair of ion channel targets associated with neurological disorders.

article source
 

<